Sign inGet started

Yanchik Connealy Pamela

Insider CIK 1796310 · IMVT Chief Financial Officer · PYXS Chief Financial Officer · OBIO Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OBIO Orchestra BioMed Holdings, A Award deriv2026-06-232026-06-2521,277— $021,277SEC↗
OBIO Orchestra BioMed Holdings, A Award2026-06-232026-06-2517,327— $066,038SEC↗
OBIO Orchestra BioMed Holdings, A Award2025-08-072025-08-0815,000— $048,711SEC↗
OBIO Orchestra BioMed Holdings, A Award deriv2025-06-242025-06-2636,797— $036,797SEC↗
OBIO Orchestra BioMed Holdings, A Award2025-06-242025-06-2612,422— $033,711SEC↗
PYXS Pyxis Oncology, Inc. A Award deriv2025-03-312025-04-02414,163$0.98 $405.9K414,163SEC↗
PYXS Pyxis Oncology, Inc. A Award deriv2024-12-232024-12-23310,000— $0310,000SEC↗
PYXS Pyxis Oncology, Inc. P Buy2024-11-262024-11-2783,400$1.96 $163.5K1,199,143SEC↗
PYXS Pyxis Oncology, Inc. P Buy2024-11-262024-11-275,450$2.00 $10.9K1,115,743SEC↗
OBIO Orchestra BioMed Holdings, A Award deriv2024-06-202024-06-2117,068— $017,068SEC↗
OBIO Orchestra BioMed Holdings, A Award2024-06-202024-06-215,376— $021,289SEC↗
PYXS Pyxis Oncology, Inc. A Award2024-03-262024-03-28328,710— $01,110,293SEC↗
PYXS Pyxis Oncology, Inc. F Tax w/h2023-11-292023-11-3036,949$1.40 $51.7K781,583SEC↗
PYXS Pyxis Oncology, Inc. P Buy2023-09-282023-09-288,000$1.87 $15.0K818,532SEC↗
PYXS Pyxis Oncology, Inc. P Buy2023-09-272023-09-276,426$1.85 $11.9K810,532SEC↗
PYXS Pyxis Oncology, Inc. P Buy2023-09-252023-09-2512,000$1.67 $20.0K804,106SEC↗
PYXS Pyxis Oncology, Inc. P Buy2023-09-222023-09-225,000$1.74 $8.7K792,106SEC↗
PYXS Pyxis Oncology, Inc. A Award2023-09-072023-09-08187,793— $0782,106SEC↗
OBIO Orchestra BioMed Holdings, A Award deriv2023-07-202023-07-2417,500— $017,500SEC↗
OBIO Orchestra BioMed Holdings, A Award2023-07-202023-07-2411,667— $015,913SEC↗
OBIO Orchestra BioMed Holdings, M Exercise deriv2023-04-122023-05-05758— $0758SEC↗
OBIO Orchestra BioMed Holdings, M Exercise2023-04-122023-05-05758— $04,246SEC↗
PYXS Pyxis Oncology, Inc. D To issuer deriv2023-03-242023-03-2810,304— $00SEC↗
PYXS Pyxis Oncology, Inc. D To issuer deriv2023-03-242023-03-28322,265— $00SEC↗
PYXS Pyxis Oncology, Inc. A Award deriv2023-03-242023-03-28322,265— $0322,265SEC↗
PYXS Pyxis Oncology, Inc. A Award deriv2023-03-242023-03-2810,304— $010,304SEC↗
PYXS Pyxis Oncology, Inc. A Award2023-03-242023-03-28209,803— $0594,313SEC↗
OBIO Orchestra BioMed Holdings, A Award deriv2023-01-262023-05-051,516— $01,516SEC↗
OBIO Orchestra BioMed Holdings, A Award deriv2023-01-262023-05-1923,250— $023,250SEC↗
OBIO Orchestra BioMed Holdings, A Award deriv2023-01-262023-01-3018,600— $018,600SEC↗
OBIO Orchestra BioMed Holdings, A Award deriv2023-01-262023-01-3023,250— $023,250SEC↗
OBIO Orchestra BioMed Holdings, A Award2023-01-262023-01-303,488— $03,488SEC↗
PYXS Pyxis Oncology, Inc. A Award2023-01-032023-01-0343,493— $0384,510SEC↗
PYXS Pyxis Oncology, Inc. A Award2022-04-142022-04-1593,493— $0341,017SEC↗
PYXS Pyxis Oncology, Inc. A Award2022-03-312022-04-04247,524— $0247,524SEC↗
PYXS Pyxis Oncology, Inc. A Award deriv2021-12-062021-12-0752,944— $052,944SEC↗
IMVT Immunovant, Inc. A Award deriv2021-03-192021-03-23162,000— $0162,000SEC↗
IMVT Immunovant, Inc. A Award2021-03-192021-03-2346,200— $046,200SEC↗
IMVT Immunovant, Inc. A Award deriv2020-05-152020-05-18180,500— $0180,500SEC↗
IMVT Immunovant, Inc. A Award deriv2019-12-182019-12-20433,588— $0433,588SEC↗